• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期诊断系统性硬化症的初级保健医生:识别和希望的基石。

The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.

机构信息

Department of Medicine (LAS), Scleroderma and Sarcoidosis Patient Care and Research Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Institute for Health and Society Medical School (JHM), University of Oslo, Norway; Alexion Pharmaceuticals (MKD), Translational Medicine Group, Cambridge, Massachusetts; and Tulane Xavier National Center of Excellence in Women's Health (JHM, MKD), The Mary Amelia Douglas-Whited Community Women's Health Education Center and Tulane University School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana.

出版信息

Am J Med Sci. 2014 Jan;347(1):54-63. doi: 10.1097/MAJ.0b013e3182a55d24.

DOI:10.1097/MAJ.0b013e3182a55d24
PMID:24366221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3872337/
Abstract

Systemic sclerosis (SSc) is a disease of unknown causative factor that manifests as a heterogenous group of multiorgan system manifestations and is characterized by vasculopathy and fibrosis of the skin and internal organs, with mortality related to pulmonary, cardiac, renal or gastrointestinal involvement. The prevalence of SSc may be underestimated in the general population. Cases are often undiagnosed or misdiagnosed, particularly cases with mild or no skin manifestations. Because of late referrals to rheumatologic care, many moderate-to-severe cases progress to irreversible end-organ damage that might have been prevented by early diagnosis. Early diagnosis of SSc with initiation of appropriate treatment is essential, with great impact on morbidity and mortality. This review examines presenting features, ensuing complications and treatment providing a focus on SSc as a treatable disease. Primary care providers play a pivotal role in recognizing initial symptoms associated with SSc and securing early diagnosis through early referral to specialists.

摘要

系统性硬化症(SSc)是一种病因不明的疾病,表现为多种器官系统表现的异质性群体,其特征是血管病变和皮肤及内脏器官纤维化,死亡率与肺部、心脏、肾脏或胃肠道受累有关。SSc 在普通人群中的患病率可能被低估。病例往往未被诊断或误诊,特别是那些皮肤表现轻微或无的病例。由于延迟转诊至风湿科治疗,许多中重度病例进展为不可逆的终末器官损伤,如果早期诊断可能会预防这些损伤。早期诊断 SSc 并开始适当治疗至关重要,这对发病率和死亡率有重大影响。本综述探讨了 SSc 的表现特征、后续并发症和治疗,重点关注 SSc 作为一种可治疗的疾病。初级保健提供者在识别与 SSc 相关的初始症状并通过早期转介至专科医生来确保早期诊断方面发挥着关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/5af8ec66fefe/nihms516848f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/eb7ce6b9ac71/nihms516848f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/45b2c1c17394/nihms516848f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/7d16f0ad4faf/nihms516848f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/da11e62fa02a/nihms516848f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/282d9e14c333/nihms516848f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/fbe4e29ce991/nihms516848f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/da0a32d12723/nihms516848f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/5af8ec66fefe/nihms516848f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/eb7ce6b9ac71/nihms516848f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/45b2c1c17394/nihms516848f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/7d16f0ad4faf/nihms516848f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/da11e62fa02a/nihms516848f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/282d9e14c333/nihms516848f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/fbe4e29ce991/nihms516848f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/da0a32d12723/nihms516848f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd8/3872337/5af8ec66fefe/nihms516848f8.jpg

相似文献

1
The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.早期诊断系统性硬化症的初级保健医生:识别和希望的基石。
Am J Med Sci. 2014 Jan;347(1):54-63. doi: 10.1097/MAJ.0b013e3182a55d24.
2
A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.系统性硬化症患者护理的综合框架:对改善 SSc 中诊断和预防策略实践的全球响应。
Best Pract Res Clin Rheumatol. 2021 Sep;35(3):101707. doi: 10.1016/j.berh.2021.101707. Epub 2021 Sep 15.
3
Clinical characteristics and mortality in systemic sclerosis: a comparison between early- and late-referred diseases.系统性硬化症的临床特征与死亡率:早诊与晚诊疾病的比较
J Med Assoc Thai. 2014 Jan;97(1):28-35.
4
Systemic sclerosis--challenges for clinical practice.系统性硬化症——临床实践面临的挑战。
Nat Rev Rheumatol. 2013 Feb;9(2):90-100. doi: 10.1038/nrrheum.2012.191. Epub 2012 Nov 13.
5
Systemic sclerosis in adults. Part I: Clinical features and pathogenesis.成人系统性硬化症。第一部分:临床特征与发病机制。
J Am Acad Dermatol. 2022 Nov;87(5):937-954. doi: 10.1016/j.jaad.2021.10.065. Epub 2022 Feb 4.
6
Recent advances in the diagnosis and treatment of systemic sclerosis.系统性硬化症诊断与治疗的最新进展
Pol Arch Med Wewn. 2013;123(1-2):51-8. doi: 10.20452/pamw.1593. Epub 2013 Jan 21.
7
Clinical Characteristics and Factors Associated With Disability and Impaired Quality of Life in Children With Juvenile Systemic Sclerosis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.儿童青少年系统性硬化症的临床特征及其与残疾和生活质量受损的相关因素:来自儿童关节炎和风湿病研究联盟遗产登记处的结果。
Arthritis Care Res (Hoboken). 2018 Dec;70(12):1806-1813. doi: 10.1002/acr.23547. Epub 2018 Nov 8.
8
Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis.系统性硬皮病相关肺动脉高压的流行病学和危险因素。
Curr Rheumatol Rep. 2013 Jan;15(1):302. doi: 10.1007/s11926-012-0302-2.
9
Ten years of a systemic sclerosis clinic in a tertiary referral centre - insights and future directions.十年系统性硬化症临床诊疗 - 深入了解与未来方向。
Acta Reumatol Port. 2021 Jul-Sep;46(3):257-265.
10
Systemic Sclerosis and Perceptions of Quality in Primary Care.系统性硬化症与基层医疗中的质量认知
Am J Med Sci. 2016 May;351(5):447-51. doi: 10.1016/j.amjms.2016.02.021. Epub 2016 Feb 17.

引用本文的文献

1
High prevalence and risk factors for osteoporosis in 1839 patients with systemic sclerosis: a systematic review and meta-analysis.1839 例系统性硬化症患者骨质疏松症的高患病率及危险因素:系统评价和荟萃分析。
Clin Rheumatol. 2023 Apr;42(4):1087-1099. doi: 10.1007/s10067-022-06460-0. Epub 2022 Dec 7.
2
Association between systemic sclerosis and peripheral arterial disease: a nationwide observation retrospective claim records cohort study in Taiwan.系统性硬化症与外周动脉疾病的相关性:台湾一项全国性观察性回顾性索赔记录队列研究。
BMJ Open. 2021 Sep 29;11(9):e048149. doi: 10.1136/bmjopen-2020-048149.
3
Automatic Quantification of Interstitial Lung Disease From Chest Computed Tomography in Systemic Sclerosis.系统性硬化症中基于胸部计算机断层扫描的间质性肺疾病自动量化
Front Med (Lausanne). 2020 Sep 25;7:577739. doi: 10.3389/fmed.2020.577739. eCollection 2020.
4
Comparative analysis of affected and unaffected areas of systemic sclerosis skin biopsies by high-throughput proteomic approaches.高通量蛋白质组学方法分析系统性硬化症皮肤活检的病变和非病变区域。
Arthritis Res Ther. 2020 May 7;22(1):107. doi: 10.1186/s13075-020-02196-x.
5
A meta-analysis of fracture risk and bone mineral density in patients with systemic sclerosis.系统性硬化症患者骨折风险与骨密度的荟萃分析。
Clin Rheumatol. 2020 Apr;39(4):1181-1189. doi: 10.1007/s10067-019-04847-0. Epub 2019 Dec 14.
6
Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis.美国商业保险系统性硬化症伴间质性肺病患者的疾病经济负担:一项理赔数据分析。
Adv Ther. 2019 May;36(5):1100-1113. doi: 10.1007/s12325-019-00929-2. Epub 2019 Mar 30.
7
Demographic associations for autoantibodies in disease-free individuals of a European population.在欧洲人群中,无症状个体的自身抗体与人口统计学的关联。
Sci Rep. 2017 Mar 28;7:44846. doi: 10.1038/srep44846.
8
Extrahepatic Manifestations of Primary Biliary Cholangitis.原发性胆汁性胆管炎的肝外表现。
Gut Liver. 2017 Nov 15;11(6):771-780. doi: 10.5009/gnl16365.
9
Systemic Sclerosis and Perceptions of Quality in Primary Care.系统性硬化症与基层医疗中的质量认知
Am J Med Sci. 2016 May;351(5):447-51. doi: 10.1016/j.amjms.2016.02.021. Epub 2016 Feb 17.

本文引用的文献

1
Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis.专家共识:对疑似系统性硬化症相关肺动脉高压进行右心导管检查:一项聚类分析德尔菲共识研究。
Ann Rheum Dis. 2014 Jan;73(1):191-7. doi: 10.1136/annrheumdis-2012-202567. Epub 2013 Jan 24.
2
Low occurrence of digital ulcers in scleroderma patients treated with bosentan for pulmonary arterial hypertension: a retrospective case-control study.硬皮病患者肺动脉高压应用波生坦治疗后发生手指溃疡的频率较低:一项回顾性病例对照研究。
Clin Rheumatol. 2013 May;32(5):679-83. doi: 10.1007/s10067-013-2172-z. Epub 2013 Jan 24.
3
Is there evidence for vasculitis in systemic sclerosis?系统性硬化症中是否存在血管炎的证据?
Curr Rheumatol Rep. 2012 Dec;14(6):516-25. doi: 10.1007/s11926-012-0296-9.
4
International Classification of Functioning, Disability and Health Core Set construction in systemic sclerosis and other rheumatic diseases: a EUSTAR initiative.国际功能、残疾和健康分类核心组构建在系统性硬化症和其他风湿性疾病中的应用:EUSTAR 倡议。
Rheumatology (Oxford). 2012 Dec;51(12):2170-6. doi: 10.1093/rheumatology/kes185. Epub 2012 Aug 23.
5
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database.EUSTAR 队列概况更新:对 EULAR 硬皮病试验和研究组数据库的分析。
Ann Rheum Dis. 2012 Aug;71(8):1355-60. doi: 10.1136/annrheumdis-2011-200742. Epub 2012 May 21.
6
Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis.Fra-2 转基因小鼠作为一种与系统性硬皮病相关的肺动脉高压新型模型。
Ann Rheum Dis. 2012 Aug;71(8):1382-7. doi: 10.1136/annrheumdis-2011-200940. Epub 2012 Apr 20.
7
IRF5 polymorphism predicts prognosis in patients with systemic sclerosis.IRF5 多态性可预测系统性硬化症患者的预后。
Ann Rheum Dis. 2012 Jul;71(7):1197-202. doi: 10.1136/annrheumdis-2011-200901. Epub 2012 Mar 22.
8
Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy.结缔组织病相关严重间质性肺病:利妥昔单抗作为挽救性治疗。
Eur Respir J. 2012 Sep;40(3):641-8. doi: 10.1183/09031936.00163911. Epub 2012 Jan 26.
9
Quantification of circulating endothelial progenitor cells in systemic sclerosis: a direct comparison of protocols.系统性硬化症中循环内皮祖细胞的定量检测:方案的直接比较。
Ann Rheum Dis. 2012 Apr;71(4):617-20. doi: 10.1136/annrheumdis-2011-200713. Epub 2012 Jan 17.
10
Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma.系统性硬皮病患者的残疾、生活质量和抑郁的决定因素。
Br J Dermatol. 2012 Feb;166(2):343-53. doi: 10.1111/j.1365-2133.2011.10624.x. Epub 2011 Dec 5.